North America Tumor Ablation Market Reach $2.12 Billion By 2032 CAGR 11.6%

North America Tumor Ablation Market Size Worth USD 2.12 Billion By 2032 | CAGR: 11.6%

The North America tumor ablation market size is expected to reach USD 2.12 Billion by 2032, according to a new study by Polaris Market Research. The report “North America Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for tumor ablation in North America is experiencing significant growth, mainly due to the increasing preference of both patients and surgeons toward minimally invasive procedures. This change is reshaping the landscape of cancer treatment, as these procedures offer numerous advantages over traditional surgical methods. Minimally invasive tumor ablation techniques, such as radiofrequency ablation, microwave ablation, and cryoablation, are gaining widespread acceptance due to their reduced invasiveness, shorter recovery times, and lower post-operative complications. These techniques also allow for targeted treatment, resulting in less damage to surrounding healthy tissue. Additionally, the rising prevalence of cancer and advancements in technology are further driving the growth of the tumor ablation market in North America.

Tumor ablation is a non-surgical, image-guided procedure in which interventional radiologists precisely target and then reduce or eliminate a tumor using either intense heat or cold. The big companies operating in tumor ablation therapy devices are concentrating on technological advancements for shorter procedures, lower exposure to radiation, and quicker learning curves, elevating safety. The tumor ablation market in North America is expected to grow due to the rising demand for minimally invasive procedures. These techniques involve the use of specialized instruments and technology, which help reduce the size of incisions, resulting in minimal disruption to the patient's body.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

North America focused on developing minimally invasive techniques and increasing precision in cancer treatment. Radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation have gained popularity due to their ability to target tumors with minimal damage to surrounding healthy tissue. Furthermore, there was growing interest in combining ablation techniques with advanced imaging technologies and real-time monitoring to improve accuracy and effectiveness. These advancements in ablation techniques have led to improved patient outcomes and reduced recovery times. Additionally, ongoing research and development in North America are also exploring the potential of using ablation techniques in combination with immunotherapy to enhance the body's immune response against cancer cells.

North America Tumor Ablation Market Report Highlights

  • The radiofrequency ablation segment held the largest market share in North America. It is extensively used in treating numerous types of cancer types, like kidney, lung, liver, and bone tumors.
  • The percutaneous ablation segment held the highest market share in North America. Percutaneous ablation provides better security, fast recovery, and less scarring.
  • Canada is anticipated to hold the fastest growth over the forecast period due to the increasing burden of cancer and the increasing cancer occurrence rate, which is 296.6 cases per 1,00,000 people every year.
  • The key market players include AngioDynamics Inc., Bioventus Inc., Boston Scientific Corp., EDAP TMS S.A., Galil Medical Inc., HealthTronics, Medtronic Plc., Mermaid Medical, Misonix, Inc., Neuwave Medical, Inc., and SonaCare Medical.

Polaris Market Research has segmented the North America tumor ablation market report based on technology, mode of treatment, application, and country:

North America Tumor Ablation, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Others

North America Tumor Ablation, Mode of Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation

North America Tumor Ablation, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

North America Tumor Ablation, Country Outlook (Revenue - USD Billion, 2019 - 2032)

  • U.S.
  • Canada

North America Tumor Ablation Market Report Scope

Report Attributes


Market size value in 2024

USD 0.88 billion

Revenue forecast in 2032

USD 2.12 billion


11.6% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments covered

By Technology, By Mode of Treatment, By Application, By Region

Country scope

U.S., Canada


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report